The self-expanding stents market size has grown strongly in recent years. It will grow from $3.49 billion in 2025 to $3.69 billion in 2026 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to increasing incidence of cardiovascular diseases, expansion of interventional cardiology procedures, advancements in stent materials, growing adoption of endovascular therapies, rising hospital catheterization lab volumes.
The self-expanding stents market size is expected to see steady growth in the next few years. It will grow to $4.47 billion in 2030 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to increasing demand for minimally invasive treatments, expansion of peripheral artery disease management, growing focus on durable vascular implants, rising adoption of advanced stent technologies, increasing healthcare investments in interventional devices. Major trends in the forecast period include increasing adoption of nitinol-based stent designs, rising demand for minimally invasive vascular procedures, growing use of self-expanding stents in peripheral interventions, expansion of drug-compatible stent platforms, enhanced focus on long-term vessel patency.
The increasing incidence of cardiovascular diseases is expected to drive the growth of the self-expanding stents market. Cardiovascular diseases are conditions that affect the heart and blood vessels, and their rising prevalence is largely attributed to factors such as obesity, an aging population, and genetic predispositions. Self-expanding stents are effective in treating cardiovascular disorders, offering minimally invasive therapeutic options for both urgent and long-term patient needs. For example, in September 2024, data from the British Heart Foundation, a UK-based cardiovascular research organization, revealed that approximately 7.6 million people in the UK are affected by heart and circulatory diseases. This includes around 4 million men and 3.6 million women living with these conditions. Cardiovascular diseases account for about 27% of all deaths in the UK, leading to over 170,000 deaths annually - roughly 480 deaths per day, or one death every three minutes. Consequently, the rising prevalence of cardiovascular diseases is fueling the growth of the self-expanding stents market.
Major companies in the self-expanding stent market are focusing on developing advanced solutions, such as drug-eluting and bioresorbable stents, to enhance vessel patency, reduce restenosis, and improve patient outcomes. Drug-eluting stents gradually release medication to prevent arterial re-narrowing, while bioresorbable stents are designed to dissolve over time after maintaining vessel openness. For instance, in June 2024, Koninklijke Philips N.V., a Netherlands-based health technology company, launched the Duo Venous Stent System in the U.S. to treat patients with venous blockages, specifically addressing symptomatic venous outflow obstruction in chronic venous insufficiency (CVI). The system includes two self-expanding stents - Duo Hybrid and Duo Extend - engineered to restore blood flow in blocked veins with flexibility, strength, and resistance to compression and vessel curvature. It aims to improve venous outflow in CVI patients while minimizing risks of stent fracture and corrosion.
In January 2024, Olympus Corporation, a Japan-based technology conglomerate, completed the acquisition of Taewoong Medical Co., Ltd. The undisclosed transaction was aimed at bolstering Olympus Corporation's gastrointestinal (GI) endotherapy product lineup and fortifying its capabilities in offering comprehensive solutions for GI treatments. Taewoong Medical Co. Ltd., based in South Korea, specializes in manufacturing self-expanding metallic stents (SEMS) for various gastrointestinal applications.
Major companies operating in the self-expanding stents market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Becton Dickinson And Company (BD Interventional), Terumo Corporation, Phenox GmbH, Balton Sp. z o.o., Biotronik SE And Co. KG, Merit Medical Systems Inc., Aesculap AG, MicroVention Inc., Lifetech Scientific Corporation, Cordis Corporation, Rontis Corporation, Veryan Medical Ltd., Andramed GmbH, Medinol Ltd., iVascular SLU, HEXACATH SAS, Eucatech AG, Endospan Ltd., Endo-Flex GmbH, Endocor GmbH.
North America was the largest region in the self-expanding stents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the self-expanding stents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the self-expanding stents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the self-expanding stents market by increasing costs of imported nitinol alloys, precision manufacturing equipment, coating materials, and delivery system components. Hospitals and device manufacturers in North America and Europe are most affected due to dependence on specialized material imports, while Asia-Pacific faces export-related pricing pressures. These tariffs are increasing device prices and impacting procurement budgets. However, they are also encouraging localized stent manufacturing, regional material sourcing, and innovation in alternative alloy and production technologies.
The self-expanding stents market research report is one of a series of new reports that provides self-expanding stents market statistics, including self-expanding stents industry global market size, regional shares, competitors with a self-expanding stents market share, detailed self-expanding stents market segments, market trends and opportunities, and any further data you may need to thrive in the self-expanding stents industry. This self-expanding stents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Self-expanding stents are medical devices engineered to open and uphold the patency (openness) of narrowed or obstructed blood vessels or tubular structures within the body. Constructed from flexible materials, often metal alloys such as nitinol, these stents possess the characteristic of self-expansion upon deployment in the body. The objective of self-expanding stents is to address various medical conditions characterized by the narrowing or occlusion of blood vessels or other tubular structures.
The primary types of self-expanding stents include gastrointestinal self-expanding stents, carotid self-expanding stents, endovascular self-expandable stents, and others. Gastrointestinal self-expanding stents are medical devices utilized for treating narrowings or blockages in the digestive tract, as they expand and provide support to the affected area. They find applications in various settings such as fem-pop artery stents, iliac artery stents, carotid artery stents, biliary stents, and others. End users of these stents include hospitals, ambulatory surgical centers, and other healthcare facilities.
The self-expanding stents market consists of sales of coronary self-expanding stents, peripheral self-expanding stents, and biliary self-expanding stents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The self-expanding stents market size is expected to see steady growth in the next few years. It will grow to $4.47 billion in 2030 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to increasing demand for minimally invasive treatments, expansion of peripheral artery disease management, growing focus on durable vascular implants, rising adoption of advanced stent technologies, increasing healthcare investments in interventional devices. Major trends in the forecast period include increasing adoption of nitinol-based stent designs, rising demand for minimally invasive vascular procedures, growing use of self-expanding stents in peripheral interventions, expansion of drug-compatible stent platforms, enhanced focus on long-term vessel patency.
The increasing incidence of cardiovascular diseases is expected to drive the growth of the self-expanding stents market. Cardiovascular diseases are conditions that affect the heart and blood vessels, and their rising prevalence is largely attributed to factors such as obesity, an aging population, and genetic predispositions. Self-expanding stents are effective in treating cardiovascular disorders, offering minimally invasive therapeutic options for both urgent and long-term patient needs. For example, in September 2024, data from the British Heart Foundation, a UK-based cardiovascular research organization, revealed that approximately 7.6 million people in the UK are affected by heart and circulatory diseases. This includes around 4 million men and 3.6 million women living with these conditions. Cardiovascular diseases account for about 27% of all deaths in the UK, leading to over 170,000 deaths annually - roughly 480 deaths per day, or one death every three minutes. Consequently, the rising prevalence of cardiovascular diseases is fueling the growth of the self-expanding stents market.
Major companies in the self-expanding stent market are focusing on developing advanced solutions, such as drug-eluting and bioresorbable stents, to enhance vessel patency, reduce restenosis, and improve patient outcomes. Drug-eluting stents gradually release medication to prevent arterial re-narrowing, while bioresorbable stents are designed to dissolve over time after maintaining vessel openness. For instance, in June 2024, Koninklijke Philips N.V., a Netherlands-based health technology company, launched the Duo Venous Stent System in the U.S. to treat patients with venous blockages, specifically addressing symptomatic venous outflow obstruction in chronic venous insufficiency (CVI). The system includes two self-expanding stents - Duo Hybrid and Duo Extend - engineered to restore blood flow in blocked veins with flexibility, strength, and resistance to compression and vessel curvature. It aims to improve venous outflow in CVI patients while minimizing risks of stent fracture and corrosion.
In January 2024, Olympus Corporation, a Japan-based technology conglomerate, completed the acquisition of Taewoong Medical Co., Ltd. The undisclosed transaction was aimed at bolstering Olympus Corporation's gastrointestinal (GI) endotherapy product lineup and fortifying its capabilities in offering comprehensive solutions for GI treatments. Taewoong Medical Co. Ltd., based in South Korea, specializes in manufacturing self-expanding metallic stents (SEMS) for various gastrointestinal applications.
Major companies operating in the self-expanding stents market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Becton Dickinson And Company (BD Interventional), Terumo Corporation, Phenox GmbH, Balton Sp. z o.o., Biotronik SE And Co. KG, Merit Medical Systems Inc., Aesculap AG, MicroVention Inc., Lifetech Scientific Corporation, Cordis Corporation, Rontis Corporation, Veryan Medical Ltd., Andramed GmbH, Medinol Ltd., iVascular SLU, HEXACATH SAS, Eucatech AG, Endospan Ltd., Endo-Flex GmbH, Endocor GmbH.
North America was the largest region in the self-expanding stents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the self-expanding stents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the self-expanding stents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the self-expanding stents market by increasing costs of imported nitinol alloys, precision manufacturing equipment, coating materials, and delivery system components. Hospitals and device manufacturers in North America and Europe are most affected due to dependence on specialized material imports, while Asia-Pacific faces export-related pricing pressures. These tariffs are increasing device prices and impacting procurement budgets. However, they are also encouraging localized stent manufacturing, regional material sourcing, and innovation in alternative alloy and production technologies.
The self-expanding stents market research report is one of a series of new reports that provides self-expanding stents market statistics, including self-expanding stents industry global market size, regional shares, competitors with a self-expanding stents market share, detailed self-expanding stents market segments, market trends and opportunities, and any further data you may need to thrive in the self-expanding stents industry. This self-expanding stents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Self-expanding stents are medical devices engineered to open and uphold the patency (openness) of narrowed or obstructed blood vessels or tubular structures within the body. Constructed from flexible materials, often metal alloys such as nitinol, these stents possess the characteristic of self-expansion upon deployment in the body. The objective of self-expanding stents is to address various medical conditions characterized by the narrowing or occlusion of blood vessels or other tubular structures.
The primary types of self-expanding stents include gastrointestinal self-expanding stents, carotid self-expanding stents, endovascular self-expandable stents, and others. Gastrointestinal self-expanding stents are medical devices utilized for treating narrowings or blockages in the digestive tract, as they expand and provide support to the affected area. They find applications in various settings such as fem-pop artery stents, iliac artery stents, carotid artery stents, biliary stents, and others. End users of these stents include hospitals, ambulatory surgical centers, and other healthcare facilities.
The self-expanding stents market consists of sales of coronary self-expanding stents, peripheral self-expanding stents, and biliary self-expanding stents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Self-Expanding Stents Market Characteristics
3. Self-Expanding Stents Market Supply Chain Analysis
4. Global Self-Expanding Stents Market Trends and Strategies
5. Self-Expanding Stents Market Analysis of End Use Industries
7. Global Self-Expanding Stents Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Self-Expanding Stents Total Addressable Market (TAM) Analysis for the Market
9. Self-Expanding Stents Market Segmentation
10. Self-Expanding Stents Market Regional and Country Analysis
11. Asia-Pacific Self-Expanding Stents Market
12. China Self-Expanding Stents Market
13. India Self-Expanding Stents Market
14. Japan Self-Expanding Stents Market
15. Australia Self-Expanding Stents Market
16. Indonesia Self-Expanding Stents Market
17. South Korea Self-Expanding Stents Market
18. Taiwan Self-Expanding Stents Market
19. South East Asia Self-Expanding Stents Market
20. Western Europe Self-Expanding Stents Market
21. UK Self-Expanding Stents Market
22. Germany Self-Expanding Stents Market
23. France Self-Expanding Stents Market
24. Italy Self-Expanding Stents Market
25. Spain Self-Expanding Stents Market
26. Eastern Europe Self-Expanding Stents Market
27. Russia Self-Expanding Stents Market
28. North America Self-Expanding Stents Market
29. USA Self-Expanding Stents Market
30. Canada Self-Expanding Stents Market
31. South America Self-Expanding Stents Market
32. Brazil Self-Expanding Stents Market
33. Middle East Self-Expanding Stents Market
34. Africa Self-Expanding Stents Market
36. Self-Expanding Stents Market Competitive Landscape and Company Profiles
37. Self-Expanding Stents Market Other Major and Innovative Companies
40. Self-Expanding Stents Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Self-Expanding Stents Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses self-expanding stents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for self-expanding stents? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The self-expanding stents market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Gastrointestinal Self-Expanding Stents; Carotid Self-Expanding Stents; Endovascular Self-Expandable Stents; Other Product Types2) By Applications: Fem-Pop Artery Stents; Iliac Artery Stents; Carotid Artery Stents; Biliary Stents; Other Applications
3) By End-Users: Hospitals; Ambulatory Surgical Centers; Other End-Users
Subsegments:
1) By Gastrointestinal Self-Expanding Stents: Esophageal Stents; Duodenal Stents; Colonic Stents2) By Carotid Self-Expanding Stents: Proximal Protection Carotid Stents; Self-Expanding Carotid Stents
3) By Endovascular Self-Expandable Stents: Aortic Stents; Renal Artery Stents; Peripheral Artery Stents
4) By Other Product Types: Biliary Self-Expanding Stents; Urological Self-Expanding Stents
Companies Mentioned: Abbott Laboratories; Medtronic PLC; Boston Scientific Corporation; Becton Dickinson And Company (BD Interventional); Terumo Corporation; Phenox GmbH; Balton Sp. z o.o.; Biotronik SE And Co. KG; Merit Medical Systems Inc.; Aesculap AG; MicroVention Inc.; Lifetech Scientific Corporation; Cordis Corporation; Rontis Corporation; Veryan Medical Ltd.; Andramed GmbH; Medinol Ltd.; iVascular SLU; HEXACATH SAS; Eucatech AG; Endospan Ltd.; Endo-Flex GmbH; Endocor GmbH
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Self-Expanding Stents market report include:- Abbott Laboratories
- Medtronic PLC
- Boston Scientific Corporation
- Becton Dickinson And Company (BD Interventional)
- Terumo Corporation
- Phenox GmbH
- Balton Sp. z o.o.
- Biotronik SE And Co. KG
- Merit Medical Systems Inc.
- Aesculap AG
- MicroVention Inc.
- Lifetech Scientific Corporation
- Cordis Corporation
- Rontis Corporation
- Veryan Medical Ltd.
- Andramed GmbH
- Medinol Ltd.
- iVascular SLU
- HEXACATH SAS
- Eucatech AG
- Endospan Ltd.
- Endo-Flex GmbH
- Endocor GmbH
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 3.69 Billion |
| Forecasted Market Value ( USD | $ 4.47 Billion |
| Compound Annual Growth Rate | 4.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 24 |
